Cigarette smoking in Parkinson's disease: influence on disease progression

Movement Disorders : Official Journal of the Movement Disorder Society
Guido AlvesJan P Larsen

Abstract

Previous studies have shown an inverse association between smoking and the prevalence of Parkinson's disease (PD), suggesting that smoking may induce a biological protection against nigral neuronal damage. In 1993, we examined the frequency of cigarette smokers among 239 patients with PD and two control groups. In addition, the progression of parkinsonism and other clinical features were followed prospectively in smoking and nonsmoking PD patients over an 8-year period. Mortality in the two PD groups was also examined. We found a 50% higher prevalence of smokers in the control groups than in patients with PD. In contrast, during the follow-up period, there were no significant differences in progression of parkinsonism, cognitive impairment, and mood in smoking and nonsmoking patients with PD. Mortality was also similar in the two groups. The lack of influence on disease progression may indicate that cigarette smoking does not have a major neuroprotective effect in patients with already diagnosed PD.

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
May 19, 1969·JAMA : the Journal of the American Medical Association·R S SchwabR R Young
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Jul 1, 1982·Journal of Neurology, Neurosurgery, and Psychiatry·R B Godwin-AustenG M Stern
Aug 1, 1981·American Journal of Epidemiology·D G HaackJ A Turbek
Jun 15, 1994·American Journal of Epidemiology·A GrandinettiD MacEachern
Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·E TandbergJ A Aarli
Jan 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·G De MicheleG Campanella
Jan 1, 1997·Annals of Neurology·F J VingerhoetsB J Snow
Apr 1, 1997·International Journal of Epidemiology·W HellenbrandG Ulm
Jan 28, 1999·Neurology·J M GorellE L Peterson
Jan 12, 2001·Acta Neurologica Scandinavica·M K BeyerJ P Larsen
Oct 20, 2001·Brain Research·M Quik, D A Di Monte
Mar 29, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Gilberto LevyKaren Marder

❮ Previous
Next ❯

Citations

Sep 20, 2008·Journal of Neurology·Guido AlvesJan Petter Larsen
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Tricia H BurdoHoward S Fox
Sep 3, 2009·Nature Reviews. Neurology·Wandana Nanhoe-MahabierBastiaan R Bloem
Oct 5, 2011·Pharmacological Reviews·Maryka Quik, Susan Wonnacott
Dec 4, 2012·Journal of Psychiatry & Neuroscience : JPN·Sharon Miksys, Rachel F Tyndale
Apr 7, 2007·Journal of Neuropathology and Experimental Neurology·Irene LitvanDonald L Price
Sep 30, 2015·Aging & Mental Health·Maxime DoironMartine Simard
Aug 12, 2009·Neuroscience and Biobehavioral Reviews·Peter DomeZoltan Rihmer
May 17, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Elisabeth B LucassenXuemei Huang
Dec 31, 2016·Journal of Alzheimer's Disease : JAD·Anne Katrine BerglandHogne Soennesyn
Oct 24, 2017·Annals of Neurology·Yoonju LeeYoung H Sohn
Apr 8, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Honglei ChenAlberto Ascherio
Oct 4, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·James F Morley, John E Duda
Mar 5, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Spiridon PapapetropoulosDeborah C Mash
Jun 5, 2010·Brain Pathology·Dag Aarsland, Martin Wilhelm Kurz
Mar 30, 2010·The European Journal of Neuroscience·Amandeep Mann, Rachel F Tyndale
Jun 30, 2005·The Journal of Biological Chemistry·Yu-Xiang XieBao-Lu Zhao
Sep 15, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Mona K BeyerJan P Larsen
Jan 26, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Judith A StrongLei Yu
Apr 7, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Anette SchragNiall P Quinn
Nov 26, 2011·Expert Review of Clinical Pharmacology·Claire ThiriezPierre Cesaro
Jan 18, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Kimberly C PaulBeate Ritz
Jan 18, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Connie Marras, Jose A Obeso
Mar 20, 2020·Molecular Neurobiology·Cole TolledoRachel F Tyndale
Jun 3, 2011·European Journal of Epidemiology·Karin WirdefeldtJack Mandel
Feb 3, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Connie MarrasUNKNOWN Parkinson Study Group DATATOP and PRECEPT investigators
Jul 8, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Ingrid de ChazeronFranck Durif
Jun 10, 2011·Journal of Neurochemistry·Ewa BromekWładysława A Daniel
Dec 18, 2019·Nigerian Medical Journal : Journal of the Nigeria Medical Association·Babawale ArabambiShamsideen Abayomi Ogun
Jul 28, 2020·Journal of Parkinson's Disease·Camilla FardellMaria Åberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Spiridon PapapetropoulosDeborah Mash
Movement Disorders : Official Journal of the Movement Disorder Society
Gilberto LevyKaren S Marder
© 2021 Meta ULC. All rights reserved